Apart from the significant role of IL-6 in invasion, migration, and thus metastasis in breast cancer, IL-6 induces proliferation in MCF-10 ductal carcinoma in situ (DCIS) cell lines, which could contribute to the progression of DCIS to invasive breast cancer [88]. Here, IL6 is linked to breast carcinoma.